Install
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
- 87articles · 30d
- 2+ day agolatest article
- Aug 14, 2026earliest in window
- 93%with images
- 233avg words
- Business & Industrial 60
- Medical 48
- Economy, Business & Finance 44
- Finance & Business 28
- Health 24
- Health & Wellness 24
- Science & Technology 17
- Science & Nature 5
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
IBD's Most Persistent Gap: Q&A with Christian Thienel
3+ day, 12+ hour ago (394+ words) Back Bay’s director discusses why IBD remains underserved — JAK inhibitor constraints, emerging oral mechanisms, and the durability gap. In 2024, Pharmaceutical Executive reported on a survey that showed a significant number of patients suffering from irritable bowel disease (IBD) struggle to…...
IBD's Most Persistent Gap and the Potential the Missing Piece: Q&A with Christian Thienel
4+ day, 12+ hour ago (296+ words) Pharmaceutical Executive In 2024, Pharmaceutical Executive reported on a survey that showed a significant number of patients suffering from irritable bowel disease (IBD) struggle to afford proper healthcare According to the results, treatments became unattainable due to barriers such as financial…...
Advancements in Oral Treatments for IBD
5+ day, 12+ hour ago (235+ words) Christian Thienel on the oral IBD mechanisms generating the most excitement — SIK2, oral IL-23, TYK2 — and why multiple could succeed. In 2024, Pharmaceutical Executive reported on a survey that showed a significant number of patients suffering from irritable bowel disease (IBD) struggle to…...
How New Therapies are Tackling Unmet Needs in IBS
1+ week, 2+ day ago (307+ words) Pharmaceutical Executive In 2024, Pharmaceutical Executive reported on a survey that showed a significant number of patients suffering from irritable bowel disease (IBD) struggle to afford proper healthcare According to the results, treatments became unattainable due to barriers such as financial…...